Cargando…
Biological Scaffolds for Congenital Heart Disease
Congenital heart disease (CHD) is the most predominant birth defect and can require several invasive surgeries throughout childhood. The absence of materials with growth and remodelling potential is a limitation of currently used prosthetics in cardiovascular surgery, as well as their susceptibility...
Autores principales: | Harris, Amy G., Salih, Tasneem, Ghorbel, Mohamed T., Caputo, Massimo, Biglino, Giovanni, Carrabba, Michele |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9854830/ https://www.ncbi.nlm.nih.gov/pubmed/36671629 http://dx.doi.org/10.3390/bioengineering10010057 |
Ejemplares similares
-
In Vitro and In Vivo Preclinical Testing of Pericyte‐Engineered Grafts for the Correction of Congenital Heart Defects
por: Alvino, Valeria Vincenza, et al.
Publicado: (2020) -
Commentary: On the road toward routine use of 3-dimensional techniques in complex congenital surgery
por: Biglino, Giovanni, et al.
Publicado: (2020) -
Graft rejection in paediatric congenital heart disease
por: Harris, Amy G., et al.
Publicado: (2023) -
Educational attainment in patients with congenital heart disease: a comprehensive systematic review and meta-analysis
por: Cocomello, Lucia, et al.
Publicado: (2021) -
Editorial: Ventricular Mechanics in Congenital Heart Disease
por: Biglino, Giovanni, et al.
Publicado: (2017)